These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23880320)

  • 1. Differential activity of c-KIT splice forms is controlled by extracellular peptide insert length.
    Phung B; Steingrímsson E; Rönnstrand L
    Cell Signal; 2013 Nov; 25(11):2231-8. PubMed ID: 23880320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
    Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
    Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
    Pedersen M; Rönnstrand L; Sun J
    Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.
    Montero JC; López-Pérez R; San Miguel JF; Pandiella A
    Haematologica; 2008 Jun; 93(6):851-9. PubMed ID: 18443272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts.
    Caruana G; Cambareri AC; Ashman LK
    Oncogene; 1999 Sep; 18(40):5573-81. PubMed ID: 10523834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1307-15. PubMed ID: 16226710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction via the stem cell factor receptor/c-Kit.
    Rönnstrand L
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2535-48. PubMed ID: 15526160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src family kinases are involved in the differential signaling from two splice forms of c-Kit.
    Voytyuk O; Lennartsson J; Mogi A; Caruana G; Courtneidge S; Ashman LK; Rönnstrand L
    J Biol Chem; 2003 Mar; 278(11):9159-66. PubMed ID: 12511554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling.
    Kazi JU; Vaapil M; Agarwal S; Bracco E; Påhlman S; Rönnstrand L
    Cell Signal; 2013 Sep; 25(9):1852-60. PubMed ID: 23707526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and oncogenic forms of the receptor tyrosine kinase kit.
    Lennartsson J; Jelacic T; Linnekin D; Shivakrupa R
    Stem Cells; 2005; 23(1):16-43. PubMed ID: 15625120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.
    Schittenhelm MM; Shiraga S; Schroeder A; Corbin AS; Griffith D; Lee FY; Bokemeyer C; Deininger MW; Druker BJ; Heinrich MC
    Cancer Res; 2006 Jan; 66(1):473-81. PubMed ID: 16397263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction by several KIT juxtamembrane domain mutations.
    Casteran N; De Sepulveda P; Beslu N; Aoubala M; Letard S; Lecocq E; Rottapel R; Dubreuil P
    Oncogene; 2003 Jul; 22(30):4710-22. PubMed ID: 12879016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the activation loop tyrosine 823 in c-Kit is crucial for cell survival and proliferation.
    Agarwal S; Kazi JU; Rönnstrand L
    J Biol Chem; 2013 Aug; 288(31):22460-8. PubMed ID: 23803604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of activation of human c-KIT kinase by internal tandem duplications of the juxtamembrane domain and point mutations at aspartic acid 816.
    Kim SY; Kang JJ; Lee HH; Kang JJ; Kim B; Kim CG; Park TK; Kang H
    Biochem Biophys Res Commun; 2011 Jul; 410(2):224-8. PubMed ID: 21640708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
    Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit.
    Sun J; Pedersen M; Rönnstrand L
    J Biol Chem; 2008 Oct; 283(41):27444-27451. PubMed ID: 18697750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
    Ali S; Ali S
    Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain.
    Jahn T; Seipel P; Coutinho S; Urschel S; Schwarz K; Miething C; Serve H; Peschel C; Duyster J
    Oncogene; 2002 Jul; 21(29):4508-20. PubMed ID: 12085229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
    Shivakrupa R; Bernstein A; Watring N; Linnekin D
    Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.